top of page
gradientForSurfBreak.png

Item List

PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in ...

Strados Labs

Portfolio Company

Carlsmed.png

TripleBlind's new outside CEO wants to take the KC startup public ...

Biz Journals

Portfolio Company

Carlsmed.png

As Part of President Biden’s Unity Agenda, White House Cancer Moonshot Announces ...

The White House

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page